6,026 research outputs found
Multi-strange particle production in relativistic heavy ion collisions at GeV
We present preliminary STAR results on measurements of multi-strange
particles , and their anti-particles from Au+Au and Cu+Cu at
GeV collisions. In order to better understand the role of
strangeness enhancement in nucleus-nucleus collisions and its scaling
properties with system size, we compare the results from Au+Au and Cu+Cu
reactions for different event centrality classes. Strangeness enhancement is
discussed in the context of multi-strange to pion ratios. Finally,
ratio is shown for different systems and energies for a
systematic study
Lateral Effects in Fermion Antibunching
Lateral effects are analyzed in the antibunching of a beam of free
non-interacting fermions. The emission of particles from a source is
dynamically described in a 3D full quantum field-theoretical framework. The
size of the source and the detectors, as well as the temperature of the source
are taken into account and the behavior of the visibility is scrutinized as a
function of these parameters.Comment: 22 pages, 4 figure
Measuring beauty production in Pb-Pb collisions at the LHC via single electrons in ALICE
We present the expected ALICE performance for the measurement of the
p_t-differential cross section of electrons from beauty decays in central Pb-Pb
collisions at the LHC.Comment: 4 pages, 2 figures, proceeding of poster presentation at "Quark
Matter 2005
Is soft physics entropy driven?
The soft physics, pT < 2 GeV/c, observables at both RHIC and the SPS have now
been mapped out in quite specific detail. From these results there is mounting
evidence that this regime is primarily driven by the multiplicity per unit
rapidity, dNch/deta. This suggests that the entropy of the system alone is the
underlying driving force for many of the global observables measured in
heavy-ion collisions. That this is the case and there is an apparent
independence on collision energy is surprising. I present the evidence for this
multiplicity scaling and use it to make some extremely naive predictions for
the soft sector results at the LHC.Comment: Proceedings of Hot Quarks 2006. 8 figures, 6 page
Treatment of human brucellosis with rifampin plus minocycline
In order to evaluate the efficacy and tolerability of a high intravenous dose of rifampin plus oral minocycline (administered daily for 3 weeks) for the treatment of acute brucellosis, we retrospectively reviewed the outcome of 239 consecutive patients (135 adults and 104 children) diagnosed and treated over a 17-year period in Italy. The combination used resulted in 100% response and a relapse rate lower than 2%. Fifty-two (30 adults and 22 children) (29.8%) complained of mild adverse effects including an increase in aspartate aminotransferase (>250 IU) observed in 12 cases and considered related to rifampin and in 11 cases a reversible hyperpigmentation of the tongue attributed to minocycline. A randomized prospective comparative study should be performed to confirm our encouraging result
Is Anomalous Production of Omega and anti-Omega Evidence for Disoriented Chiral Condensates?
No conventional picture of nucleus-nucleus collisions has yet been able to
explain the abundance of Omega and anti-Omega hyperons in central collisions
between Pb nuclei at 158 A GeV at the CERN SPS. We argue that this is evidence
that they are produced as topological defects arising from the formation of
disoriented chiral condensates (DCC) with an average domain size of about 2 fm.Comment: version 2 containing formulas, accepted by PR
Strange Hadron Resonances and QGP Freeze-out
We describe how the abundance and distribution of hyperon resonances can be
used to probe freeze-out conditions. We demonstrate that resonance yields allow
us to measure the time scales of chemical and thermal freeze-outs. This should
permit a direct differentiation between the explosive sudden, and staged
adiabatic freeze-out scenarios.Comment: 8 pages including 4 figures, in Proceedings of Strange Quark Matter
2001, Frankfurt, submitted to J. Phys. G version 2: refernces
corrected/added, numercial corrections in figures 2,3,
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies
Monocyte-derived macrophages (M/M) are considered the second cellular target of HIV-1 and a crucial virus reservoir. M/M are widely distributed in all tissues and organs, including the CNS, where they represent the most common HIV-infected cells. Differently from activated CD4+ T lymphocytes, M/M are resistant to the cytopathic effect of HIV and survive HIV infection for a long lime. Moreover, HIV-1 replication in M/M is a key pathogenetic event during the course of HIV-1 infection. Overall findings strongly support the clinical relevance of anti-HIV drugs in M/M. Nucleoside RT inhibitors (NRTIs) are more active against HIV in M/M than in CD4+ T lymphocytes. Their activity is further boosted by the presence of an additional monophosphate group (i.e., a phosphonate group, as in the case of Tenofovir), thus overcoming the bottleneck of the low phosphorylation ability of M/M. In contrast, the antiviral activity of non-NRTIs (not affecting the DNA chain elongation) in M/M is similar to that in CD4+ T lymphocytes. Protease inhibitors are the only clinically approved drugs acting at a late stage of the HIV lifecycle. They are able to interfere with HIV replication in HIV-1 chronically infected M/M, even if at concentrations greater than those observed in HIV-1 chronically infected CD4+ T lymphocytes. Finally, several new drugs have been shown to interfere efficiently with HIV replication in M/M, including entry inhibitors. A better understanding of the activity of the anti-HIV drugs in M/M may represent a key element for the design of effective anti-HIV chemotherapy. © Society for Leukocyte Biology
Recent results on strangeness production from NA49
We present a summary of measurements of strange particles performed by the
experiment NA49 in inelastic p+p interactions, as well as semi-central C+C and
Si+Si, central Pb+Pb, and minimum bias Pb+Pb collisions in the energy range
= 6.3 - 17.3 GeV. New results on , and
production in minimum bias Pb+Pb collisions at = 8.7 and 17.3
are shown. Furthermore the strangeness enhancement factor at =
17.3 GeV is presented and compared to the results from NA57 and STAR. Energy
dependence of strange particle yields normalized to pion yields is presented.
New data on production are shown at = 17.3
GeV. Furthermore we present the energy dependence of and
fluctuations. The data are compared with model predictions.Comment: 9 pages, 7 figures, Submitted to J. Phys. G (Proceedings of the
International Conference on Strangeness in Quark Matter, Buzios, Rio de
Janeiro, Brazil, September 27 - October 2, 2009
- …
